Nadège Vimond

2.3k total citations
14 papers, 698 citations indexed

About

Nadège Vimond is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Nadège Vimond has authored 14 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Nadège Vimond's work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Nadège Vimond is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Nadège Vimond collaborates with scholars based in France, Estonia and Switzerland. Nadège Vimond's co-authors include Nathalie Jacques, Philippe Vielh, Fanny Billiot, Ludovic Lacroix, Karim Fizazi, Sylvestre Le Moulec, F Farace, Jean‐Charles Soria, Françoise Drusch and David Planchard and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Nadège Vimond

14 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadège Vimond France	11	439	265	185	140	123	14	698
Ik Sun Kim United States	4	466 1.1×	187 0.7×	256 1.4×	144 1.0×	302 2.5×	5	756
Amit Goldstein United States	6	485 1.1×	169 0.6×	282 1.5×	181 1.3×	246 2.0×	6	781
Ece Kadioglu Switzerland	7	462 1.1×	255 1.0×	430 2.3×	128 0.9×	355 2.9×	8	883
Jinghui Cheng China	5	280 0.6×	178 0.7×	276 1.5×	108 0.8×	289 2.3×	9	683
Inge Lodewijckx Belgium	5	425 1.0×	119 0.4×	273 1.5×	132 0.9×	291 2.4×	7	738
Anita Brandstetter Austria	10	460 1.0×	96 0.4×	212 1.1×	209 1.5×	215 1.7×	12	769
Martina Schmittnaegel Switzerland	7	405 0.9×	146 0.6×	275 1.5×	92 0.7×	427 3.5×	8	761
Marissa S. Mattar United States	12	313 0.7×	175 0.7×	290 1.6×	230 1.6×	153 1.2×	22	666
Mutsuko Ibusuki Japan	16	488 1.1×	407 1.5×	347 1.9×	94 0.7×	82 0.7×	36	938
Christine To Canada	9	323 0.7×	196 0.7×	391 2.1×	173 1.2×	60 0.5×	11	708

Countries citing papers authored by Nadège Vimond

Since Specialization

Citations

This map shows the geographic impact of Nadège Vimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Vimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Vimond more than expected).

Fields of papers citing papers by Nadège Vimond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Vimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Vimond. The network helps show where Nadège Vimond may publish in the future.

Co-authorship network of co-authors of Nadège Vimond

This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Vimond. A scholar is included among the top collaborators of Nadège Vimond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Vimond. Nadège Vimond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Salama, Apolline, Séverine Bézie, Laurent Tesson, et al.. (2022). IL‐34 deficiency impairs FOXP3⁺ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis. Clinical and Translational Medicine. 12(8). e988–e988. 13 indexed citations

Bézie, Séverine, et al.. (2022). 344.9: Clinical Grade CD8+T Regulatory Cells Moving Forward in Human Transplantation. Transplantation. 106(9S). S341–S341. 1 indexed citations

Lasselin, Juliette, Séverine Bézie, Léa Flippe, et al.. (2022). Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8 ⁺ Regulatory T Cells. Neurology Neuroimmunology & Neuroinflammation. 9(6). 7 indexed citations

Bézie, Séverine, et al.. (2020). IL-34 Actions on FOXP3+ Tregs and CD14+ Monocytes Control Human Graft Rejection. Frontiers in Immunology. 11. 1496–1496. 22 indexed citations

Bézie, Séverine, Nadège Vimond, Ignacio Anegón, & Carole Guillonneau. (2020). CELL THERAPY USING CD8+TREGS IN HUMAN TRANSPLANTATION. Transplantation. 104(S3). S204–S204. 2 indexed citations

Vimond, Nadège, Juliette Lasselin, Ignacio Anegón, Carole Guillonneau, & Séverine Bézie. (2020). Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors. Molecular Therapy — Methods & Clinical Development. 20. 69–85. 13 indexed citations

Thiolat, Allan, Séverine Bézie, Michael Schmueck‐Henneresse, et al.. (2020). Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease. Blood Advances. 4(11). 2501–2515. 11 indexed citations

Ouisse, Laure‐Hélène, Séverine Remy, Aude Lafoux, et al.. (2019). Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment. Frontiers in Immunology. 10. 2131–2131. 19 indexed citations

Bézie, Séverine, Béatrice Charreau, Nadège Vimond, et al.. (2019). Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice. Blood Advances. 3(22). 3522–3538. 57 indexed citations

10.

Boige, Valérie, David Malka, Abderrahmane Bourredjem, et al.. (2012). Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma. The Oncologist. 17(8). 1063–1072. 105 indexed citations

11.

Farace, F, Christophe Massard, Nadège Vimond, et al.. (2011). A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. British Journal of Cancer. 105(6). 847–853. 325 indexed citations

12.

Malka, David, Valérie Boige, Nathalie Jacques, et al.. (2011). Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab. Annals of Oncology. 23(4). 919–927. 39 indexed citations

13.

Farace, Françoise, Marine Gross‐Goupil, Elodie Tournay, et al.. (2011). Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. British Journal of Cancer. 104(7). 1144–1150. 44 indexed citations

14.

Jacques, Nathalie, Nadège Vimond, Rosa Conforti, et al.. (2008). Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay. Journal of Immunological Methods. 337(2). 132–143. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact